<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36773494</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7603</ISSN><JournalIssue CitedMedium="Internet"><Volume>156</Volume><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of reproductive immunology</Title><ISOAbbreviation>J Reprod Immunol</ISOAbbreviation></Journal><ArticleTitle>Serological autoimmune profile of systemic lupus erythematosus in deep and non-deep endometriosis patients.</ArticleTitle><Pagination><StartPage>103827</StartPage><MedlinePgn>103827</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jri.2023.103827</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0165-0378(23)00033-5</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Several studies have reported a high prevalence of autoimmune diseases such as systemic lupus erythematosus (SLE) in endometriosis patients. The aim of this study was to evaluate the SLE autoimmune antibody profile in patients with deep (DE) and non-deep endometriosis (Non-DE).</AbstractText><AbstractText Label="MATERIALS AND METHODS">Four groups of premenopausal patients were evaluated: patients with DE (n&#xa0;=&#xa0;50); patients with ovarian endometriomas (Non-DE; n&#xa0;=&#xa0;50); healthy patients without endometriosis (C group; n&#xa0;=&#xa0;45); and SLE patients without endometriosis (SLE group; N&#xa0;=&#xa0;46). Blood samples were obtained and the standard SLE autoimmune profile was evaluated in all patients. Pain symptoms related to endometriosis and clinical SLE manifestations were also recorded.</AbstractText><AbstractText Label="RESULTS">The DE group presented a statistically significant higher proportion of patients with antinuclear antibodies (ANA) (20%) compared to the Non-DE group (4%) and C group (2.2%). Levels of complement were more frequently lower among DE and Non-DE patients although differences did not reach statistical significance. Similarly, anti-dsDNA antibodies and anticoagulant lupus were positive in more patients of the DE group but did not reach statistical significance. The DE group complained of more arthralgia and asthenia compared to the Non-DE and C groups.</AbstractText><AbstractText Label="CONCLUSIONS">The results of this study showed higher positivity of ANA and greater arthralgia and asthenia in patients with DE compared with Non-DE patients and healthy controls, suggesting that they may have a higher susceptibility to autoimmune diseases and present more generalized pain.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Coloma</LastName><ForeName>J L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Gynaecology, Institut Cl&#xed;nic of Gynaecology, Obstetrics and Neonatology, Hospital Cl&#xed;nic of Barcelona, Faculty of Medicine-University of Barcelona, Institut d&#xb4;Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Villarroel, 170, 08036&#xa0;Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez-Zamora</LastName><AffiliationInfo><Affiliation>Department of Gynaecology, Institut Cl&#xed;nic of Gynaecology, Obstetrics and Neonatology, Hospital Cl&#xed;nic of Barcelona, Faculty of Medicine-University of Barcelona, Institut d&#xb4;Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Villarroel, 170, 08036&#xa0;Barcelona, Spain. Electronic address: mazamora@clinic.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>T&#xe0;ssies</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Hemotherapy and Hemostasis, Hospital Cl&#xed;nic of Barcelona, Villarroel, 170, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reverter</LastName><ForeName>J C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Hemotherapy and Hemostasis, Hospital Cl&#xed;nic of Barcelona, Villarroel, 170, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Espinosa</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Autoimmune Diseases, Hospital Cl&#xed;nic of Barcelona, Villarroel, 170, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cervera</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Autoimmune Diseases, Hospital Cl&#xed;nic of Barcelona, Villarroel, 170, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carmona</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Gynaecology, Institut Cl&#xed;nic of Gynaecology, Obstetrics and Neonatology, Hospital Cl&#xed;nic of Barcelona, Faculty of Medicine-University of Barcelona, Institut d&#xb4;Investigacions Biom&#xe8;diques August Pi i Sunyer (IDIBAPS), Villarroel, 170, 08036&#xa0;Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>J Reprod Immunol</MedlineTA><NlmUniqueID>8001906</NlmUniqueID><ISSNLinking>0165-0378</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000974">Antibodies, Antinuclear</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004715" MajorTopicYN="Y">Endometriosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001247" MajorTopicYN="N">Asthenia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000974" MajorTopicYN="N">Antibodies, Antinuclear</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antinuclear antibodies</Keyword><Keyword MajorTopicYN="N">Asthenia</Keyword><Keyword MajorTopicYN="N">Autoimmunity</Keyword><Keyword MajorTopicYN="N">Endometriosis</Keyword><Keyword MajorTopicYN="N">Pain, arthralgia</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>11</Day><Hour>18</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36773494</ArticleId><ArticleId IdType="doi">10.1016/j.jri.2023.103827</ArticleId><ArticleId IdType="pii">S0165-0378(23)00033-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>